Page last updated: 2024-10-26

felbamate and Drug Refractory Epilepsy

felbamate has been researched along with Drug Refractory Epilepsy in 3 studies

Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.

Research Excerpts

ExcerptRelevanceReference
"Felbamate has been approved for refractory partial seizures since the early nineties."5.42The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame? ( Billa, G; Chudasama, H; Goswami, S; Rane, J; Shah, R; Thakkar, K, 2015)
"Felbamate is a second-generation antiepileptic drug that can be used as add-on therapy to standard antiepileptic drugs."2.82Felbamate add-on therapy for drug-resistant focal epilepsy. ( Bresnahan, R; Dong, J; Geng, J; Martin-McGill, KJ; Ni, H; Shi, LL, 2022)
"Felbamate is a second-generation antiepileptic drug that can be used as add-on therapy to standard antiepileptic drugs."2.61Felbamate add-on therapy for drug-resistant focal epilepsy. ( Bresnahan, R; Dong, J; Geng, J; Martin-McGill, KJ; Ni, H; Shi, LL, 2019)
"Felbamate has been approved for refractory partial seizures since the early nineties."1.42The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame? ( Billa, G; Chudasama, H; Goswami, S; Rane, J; Shah, R; Thakkar, K, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Shi, LL2
Bresnahan, R2
Martin-McGill, KJ2
Dong, J2
Ni, H2
Geng, J2
Thakkar, K1
Billa, G1
Rane, J1
Chudasama, H1
Goswami, S1
Shah, R1

Reviews

2 reviews available for felbamate and Drug Refractory Epilepsy

ArticleYear
Felbamate add-on therapy for drug-resistant focal epilepsy.
    The Cochrane database of systematic reviews, 2022, 08-01, Volume: 8

    Topics: Anticonvulsants; Drug Resistant Epilepsy; Drug Therapy, Combination; Drug-Related Side Effects and A

2022
Felbamate add-on therapy for drug-resistant focal epilepsy.
    The Cochrane database of systematic reviews, 2019, 08-01, Volume: 8

    Topics: Anticonvulsants; Drug Resistant Epilepsy; Felbamate; Humans; Phenylcarbamates; Propylene Glycols; Qu

2019

Other Studies

1 other study available for felbamate and Drug Refractory Epilepsy

ArticleYear
The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame?
    Expert review of neurotherapeutics, 2015, Volume: 15, Issue:12

    Topics: Anemia, Aplastic; Anticonvulsants; Drug Resistant Epilepsy; Epilepsies, Partial; Felbamate; Humans;

2015